Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy
Article in Seminars in Immunology (October 2022)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease
Article in Chinese Chemical Letters (October 2022)
Antioxidative Self-Assembling Nanoparticles Attenuate the Development of Steatohepatitis and Inhibit Hepatocarcinogenesis in Mice
Article in Antioxidants (September 2022)